Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
At 4mg per week: Draw 0.8mL = 80 units
Combination research specifically explores whether the non-overlapping mechanisms produce additive or synergistic effects in tissue-repair model systems, a multi-mechanism approach that single-peptide pharmacology cannot address
Ready to get started
DOI: 10.3390/ijms19071987 BPC-157 angiogenic signaling VEGFR2-Akt-eNOS activation, nitric oxide bioavailability, FAK-paxillin cell-anchoring cascade, anti-cytokine modulation: PMC8275860 TB-4 / TB-500 G-actin sequestration and threshold-saturation mechanism actin-monomer binding, cytoskeletal mobilization for cell migration, mass-action pharmacodynamics requiring bolus dosing: PubMed 12581423 TB-4 Ac-SDKP anti-fibrotic fragment N-terminal tetrapeptide (fragment 14) released by meprin- and POP processing
US$ 21.92
US$ 22.55
US$ 24.11
US$ 29.23
